» Articles » PMID: 30101552

Systematic Review of the Impact of Point-of-care Testing for Influenza on the Outcomes of Patients with Acute Respiratory Tract Infection

Overview
Journal Rev Med Virol
Publisher Wiley
Specialty Microbiology
Date 2018 Aug 14
PMID 30101552
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Acute respiratory tract infections are a major cause of morbidity and mortality and represent a significant burden on the health care system. Laboratory testing is required to definitively distinguish infecting influenza virus from other pathogens, resulting in prolonged emergency department (ED) visits and unnecessary antibiotic use. Recently available rapid point-of-care tests (POCT) may allow for appropriate use of antiviral and antibiotic treatments and decrease patient lengths of stay. We undertook a systematic review to assess the effect of POCT for influenza on three outcomes: (1) antiviral prescription, (2) antibiotic prescription, and (3) patient length of stay in the ED. The databases Medline and Embase were searched using MeSH terms and keywords for influenza, POCT, antivirals, antibiotics, and length of stay. Amongst 245 studies screened, 30 were included. The majority of papers reporting on antiviral prescription found that a positive POCT result significantly increased use of antivirals for influenza compared with negative POCT results and standard supportive care. A positive POCT result also led to decreased antibiotic use. The results of studies assessing the effect of POCT on ED length of stay were not definitive. The studies assessed in this systematic review support the use of POCT for diagnosis of influenza in patients suffering an acute respiratory infection. Diagnosis using POCT may lead to more appropriate prescription of treatments for infectious agents. Further studies are needed to assess the effect of POCT on the length of stay in ED.

Citing Articles

The Impact of Rapid Molecular Diagnostics for Influenza on Antibiotic Stewardship in the Emergency Department-An Observational Retrospective Study.

Roth E, Cattaneo M, Hollenstein Y, Weisser M, Bassetti S, Tschudin Sutter S Antibiotics (Basel). 2025; 14(2).

PMID: 40001364 PMC: 11851583. DOI: 10.3390/antibiotics14020120.


Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review.

Mojebi A, Wu P, Keeping S, Hale B, Chase J, Beaubrun A PLoS One. 2024; 19(6):e0303560.

PMID: 38870136 PMC: 11175541. DOI: 10.1371/journal.pone.0303560.


The Role and Value of Professional Rapid Testing of Acute Respiratory Infections (ARIs) in Europe: A Special Focus on the Czech Republic, Poland, and Romania.

Drevinek P, Flisiak R, Nemes R, Nogales Crespo K, Tomasiewicz K Diagnostics (Basel). 2024; 14(6).

PMID: 38535051 PMC: 10969707. DOI: 10.3390/diagnostics14060631.


Accurate detection of influenza A virus by use of a novel cross-priming isothermal amplification-based point-of-care assay.

Deng J, Zhu H, An S, Huang H, Wang R, Chen Y Microbiol Spectr. 2024; 12(3):e0307423.

PMID: 38349165 PMC: 10913471. DOI: 10.1128/spectrum.03074-23.


ECHOPvir: A Mixture of Echinacea and Hop Extracts Endowed with Cytoprotective, Immunomodulatory and Antiviral Properties.

Percaccio E, De Angelis M, Acquaviva A, Nicotra G, Ferrante C, Mazzanti G Nutrients. 2023; 15(20).

PMID: 37892456 PMC: 10609862. DOI: 10.3390/nu15204380.


References
1.
McCullough A, Pollack A, Hansen M, Glasziou P, Looke D, Britt H . Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations. Med J Aust. 2017; 207(2):65-69. DOI: 10.5694/mja16.01042. View

2.
Brendish N, Malachira A, Armstrong L, Houghton R, Aitken S, Nyimbili E . Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med. 2017; 5(5):401-411. PMC: 7164815. DOI: 10.1016/S2213-2600(17)30120-0. View

3.
Iyer S, Gerber M, Pomerantz W, Mortensen J, Ruddy R . Effect of point-of-care influenza testing on management of febrile children. Acad Emerg Med. 2006; 13(12):1259-68. DOI: 10.1197/j.aem.2006.07.026. View

4.
Popowitch E, Miller M . Performance Characteristics of Xpert Flu/RSV XC Assay. J Clin Microbiol. 2015; 53(8):2720-1. PMC: 4508419. DOI: 10.1128/JCM.00972-15. View

5.
Rogers B, Shankar P, Jerris R, Kotzbauer D, Anderson E, Watson J . Impact of a rapid respiratory panel test on patient outcomes. Arch Pathol Lab Med. 2014; 139(5):636-41. DOI: 10.5858/arpa.2014-0257-OA. View